We have demonstrated that miR-9-5p regulates the expression of the serine/threonine kinase PAK4, providing strong evidence that miR-9-5p inhibits CRC proliferation and survival through negative regulation of PAK4. Here, MARK2 is linked to colorectal carcinoma.